Midodrin Substipharm 2
Midodrin Substipharm 2 is a medicine authorised by Swissmedic under authorisation number 69384. The authorisation holder is Leman SKL SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 January 2025 and the authorisation is limited until 21 January 2030. ATC code C01CA17 places the medicine in the group Cardiac therapy.
| Authorisation number | 69384 |
|---|---|
| Name | Midodrin Substipharm 2 |
| Full name | Midodrin Substipharm 2,5 mg, comprimés |
| Authorisation holder | Leman SKL SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C01CA17 |
| First authorisation | 22 January 2025 |
| Authorisation validity | 21 January 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Midodrin Substipharm 2,5 mg, comprimés | B | 22 January 2025 |
| 2 | Midodrin Substipharm 5 mg, comprimés | B | 22 January 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 5 | 20 | Tablette(n) | C01CA17 | 02.05.2. | B |
| 6 | 50 | Tablette(n) | C01CA17 | 02.05.2. | B |
| 7 | 20 | Tablette(n) | C01CA17 | 02.05.2. | B |
| 8 | 50 | Tablette(n) | C01CA17 | 02.05.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Midodrin Substipharm 2 authorised in Switzerland?
Yes. Midodrin Substipharm 2 is authorised by Swissmedic under authorisation number 69384, data as of 01 September 2026. The authorisation is limited until 21 January 2030.
Which dispensing category does Midodrin Substipharm 2 have?
Midodrin Substipharm 2 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Midodrin Substipharm 2?
The authorisation holder is Leman SKL SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.